Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin

Annals of Hematology · Published 2010-11-01 · Journal article · DOI 10.1007/s00277-010-0992-3 · Cited by 56 (Crossref)

Authors (10)

Gabriele Buda, Deborah Ricci, C. Chris Huang, Reyna Favis, Nadine Cohen, Sen H. Zhuang, Jean-Luc Harousseau, Pieter Sonneveld, Joan Bladé, Robert Z. Orlowski

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Volume
89
Issue
11
Pages
1133-1140
Year
2010

Citation

Buda, G., Ricci, D., Huang, C., et al. (2010). Polymorphisms in the multiple drug resistance protein 1 and in P-glycoprotein 1 are associated with time to event outcomes in patients with advanced multiple myeloma treated with bortezomib and pegylated liposomal doxorubicin. Annals of Hematology. https://doi.org/10.1007/s00277-010-0992-3

Related articles

Metrics

Citations (Crossref)
56